Cystic Fibrosis Foundation

Cystic Fibrosis Foundation
Name	Cystic Fibrosis Foundation
Type	Nonprofit organization
Founded	1955
Founder	Bernard A. Friedman; Helen I. McLary
Headquarters	Bethesda, Maryland
Area served	United States
Focus	Cystic fibrosis research, patient care, advocacy

Cystic Fibrosis Foundation The Cystic Fibrosis Foundation is an American nonprofit organization dedicated to curing cystic fibrosis and supporting people affected by the disease through research funding, care standards, and advocacy. Founded in 1955, the Foundation has played a central role in sponsoring clinical trials, establishing treatment networks, and advancing therapies that transformed survival and quality of life for people with cystic fibrosis. Its work intersects with major biomedical institutions, pharmaceutical companies, and patient communities across the United States.

History

The Foundation was established in 1955 by a group of parents and clinicians responding to rising awareness of cystic fibrosis following publications in journals like the Journal of Pediatrics and conferences at institutions such as Johns Hopkins Hospital. Early collaborations included clinicians from Boston Children's Hospital, Children's Hospital of Philadelphia, and researchers at Columbia University and University of Michigan. During the 1960s and 1970s the Foundation supported newborn screening pilots influenced by guidelines from American Academy of Pediatrics committees and coordinated multi-center studies with teams at Mayo Clinic and Cleveland Clinic. In the 1980s and 1990s the organization expanded its role in research infrastructure, funding molecular genetics work at laboratories associated with University of California, San Francisco and Massachusetts General Hospital, which paralleled discoveries at genome centers such as Cold Spring Harbor Laboratory and Sanger Centre. The 21st century saw the Foundation take a strategic role in drug development partnerships with firms like Vertex Pharmaceuticals and collaborations with regulatory agencies including the Food and Drug Administration.

Mission and Programs

The Foundation's mission emphasizes ending cystic fibrosis and improving care, reflected in programs that fund basic science at institutions such as Harvard Medical School, Stanford University School of Medicine, and University of Pennsylvania Perelman School of Medicine. Clinical initiatives connect care centers modeled after protocols from National Institutes of Health consortia and specialty clinics like those at Seattle Children's Hospital and Texas Children's Hospital. Educational programs draw on patient engagement models from organizations like American Lung Association and March of Dimes, and public awareness campaigns have paralleled efforts used by American Cancer Society and Alzheimer's Association. Training fellowships and grants coordinate with professional societies including American Thoracic Society and European Respiratory Society collaborators.

Research and Drug Development

The Foundation has been a prominent funder of translational research, supporting gene discovery that built on earlier work at Howard Hughes Medical Institute-affiliated laboratories and resources from the Human Genome Project. It created therapeutic pipelines by underwriting early-stage trials at research hospitals such as University of North Carolina School of Medicine and partnering with biotech firms including Amgen, Genentech, and Novartis. High-profile collaborations with Vertex Pharmaceuticals led to approvals mediated by Food and Drug Administration panels, shifting treatment paradigms similarly to breakthroughs seen in fields involving Gilead Sciences and Roche. The Foundation sponsors registries and natural history studies modeled after databases at Centers for Disease Control and Prevention and data-sharing initiatives with consortia like Global Alliance for Genomics and Health.

Patient Support and Care Network

The Foundation established a network of accredited care centers patterned after multidisciplinary teams at St. Jude Children's Research Hospital and Mount Sinai Health System, linking pulmonologists, dietitians, and physical therapists trained under fellowship programs from American Board of Pediatrics-aligned institutions. Patient education resources mirror approaches used by National Institutes of Health institutes and community outreach efforts similar to those of Susan G. Komen and United Way. Support camps, transition programs, and mental health services have ties to models developed by Ronald McDonald House Charities and youth programs run by YMCA. The registry and quality improvement initiatives coordinate benchmarking methods comparable to those employed by The Joint Commission and professional collaboratives at Johns Hopkins Bloomberg School of Public Health.

Advocacy and Public Policy

Advocacy work includes lobbying and coalition-building with groups like EveryLife Foundation for Rare Diseases and engagement with federal actors including members of United States Congress and agencies such as Centers for Medicare & Medicaid Services. Policy priorities have included newborn screening mandates similar to campaigns by March of Dimes and reimbursement issues resonant with debates involving Association of American Medical Colleges and American Medical Association. The Foundation has participated in public hearings at Kennedy Caucus-style briefings and partnered with patient advocacy networks modeled on Rare Disease Legislative Advocates.

Funding and Financials

Revenue streams historically include individual donations, community fundraising events inspired by models like Relay For Life and corporate partnerships with pharmaceutical companies including Vertex Pharmaceuticals, Pfizer, and Bristol-Myers Squibb. The Foundation has invested in venture-style initiatives and royalty agreements that generated proceeds reported in nonprofit filings akin to those of Howard Hughes Medical Institute-funded spinouts. Financial stewardship involved audits and governance practices comparable to standards from Charity Navigator evaluations and nonprofit law frameworks guided by Internal Revenue Service rules. Endowment management and grantmaking coordinate with practices used by foundations such as Gates Foundation and Robert Wood Johnson Foundation.

Category:Medical and health foundations in the United States